Trial Profile
Long-term Effect of Tolvaptan Administration for Outcome and Neurohormonal Factors in Patients with Heart Failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jul 2017
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- 23 Jul 2017 Status changed from recruiting to completed.
- 01 Jul 2014 New trial record